A study in The Journal of Cell Biology by scientists at the University of Massachusetts Medical School reveals notable new details approximately the inner workings of the CRISPR-Cas9 machinery in live cells that may have implications for the development of therapeutics that employ the powerful gene editing tool.
Source: phys.org